Convalescent plasma in hospitalised patients with <scp>COVID</scp> ‐19
Fewer participants allocated to CP died or required new intensive respiratory or vasopressors/inotropic support in the 28 days after randomisation compared to standard care. However, our trial was stopped early in response to external evidence, and our sample size was small, limiting any definitive conclusions regarding the efficacy or safety of CP.
Authors
- Grace McPhee (ORCID: https://orcid.org/0000-0003-1292-8458)
- James Daly (ORCID: https://orcid.org/0000-0002-6008-0386)
- Tom Snelling (ORCID: https://orcid.org/0000-0003-4670-0638)
- Adam G. Stewart (ORCID: https://orcid.org/0000-0002-7262-7529)
- David L. Paterson (ORCID: https://orcid.org/0000-0003-2079-4437)
- Justin T. Denholm (ORCID: https://orcid.org/0000-0002-9214-6431)
- Joshua Saul Davis (ORCID: https://orcid.org/0000-0001-9864-5699)
- Susan C. Morpeth (ORCID: https://orcid.org/0000-0002-6131-8536)
- Matthew O’Sullivan (ORCID: https://orcid.org/0000-0001-8783-5323)
- Iain B. Gosbell (ORCID: https://orcid.org/0000-0001-5245-5152)
- Vivekanand Jha (ORCID: https://orcid.org/0000-0002-8015-9470)
- Benjamin A. Rogers (ORCID: https://orcid.org/0000-0001-6515-2118)
- Megan Rees (ORCID: https://orcid.org/0000-0002-7736-4000)
- Damian F. J. Purcell (ORCID: https://orcid.org/0000-0002-4485-1726)
- Veronica C. Hoad (ORCID: https://orcid.org/0000-0002-7827-3661)
- James S. Molton (ORCID: https://orcid.org/0000-0002-2916-2818)
- Erica M. Wood (ORCID: https://orcid.org/0000-0001-7527-2340)
- Vi Nguyen (ORCID: https://orcid.org/0000-0002-0688-0286)
- Kylie Alcorn (ORCID: https://orcid.org/0000-0003-2591-483X)
- Lyn‐li Lim (ORCID: https://orcid.org/0000-0003-1782-7875)
- Asha C Bowen (ORCID: https://orcid.org/0000-0002-3242-1155)
- Steven Y. C. Tong (ORCID: https://orcid.org/0000-0002-1368-8356)
- Thomas Hills (ORCID: https://orcid.org/0000-0003-0322-5822)
- Naomi E. Hammond (ORCID: https://orcid.org/0000-0002-6559-7747)
- Joe Sasadeusz (ORCID: https://orcid.org/0000-0001-7438-0382)
- Niamh Meagher (ORCID: https://orcid.org/0000-0001-5324-8307)
- Susan R. Goulding (ORCID: https://orcid.org/0000-0003-4237-4804)
- David J. Price (ORCID: https://orcid.org/0000-0003-0076-3123)
- Zoe McQuilten (ORCID: https://orcid.org/0000-0001-9698-7185)
- Peta Edler (ORCID: https://orcid.org/0000-0002-3233-6620)
- Balasubramanian Venkatesh (ORCID: https://orcid.org/0000-0003-2893-6954)
- Hong Foo
Institutions
- The University of Sydney (AU)
- Queensland Health (AU)
- New South Wales Department of Health (AU)
- The Royal Melbourne Hospital (AU)
- Manipal Academy of Higher Education (IN)
- The University of Queensland (AU)
- The University of Melbourne (AU)
- National University of Singapore (SG)
- The Kids Research Institute Australia (AU)
- Australian Red Cross Lifeblood (AU)
- Université de Montpellier (FR)
- Royal Brisbane and Women's Hospital (AU)
- Royal North Shore Hospital (AU)
- Gold Coast Hospital (AU)
- Middlemore Hospital (NZ)
- Princess Margaret Hospital for Children (AU)
- Liverpool Hospital (AU)
- Wellington Hospital (NZ)
- Auckland City Hospital (NZ)
- Westmead Hospital (AU)
- UNSW Sydney (AU)
- Hunter Medical Research Institute (AU)
- Metro South Health (AU)
- Peter Doherty Institute (AU)
- The George Institute for Global Health (AU)
- Western Health (AU)
- Monash Health (AU)
- Medical Research Institute of New Zealand (NZ)
- George Institute for Global Health (IN)
- Westmead Institute for Medical Research (AU)
- National University Health System (SG)
- Perth Children's Hospital
- Imperial College London (GB)
- Monash University (AU)
- Université de Nîmes (FR)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2025-11-22
- DOI
- https://doi.org/10.1111/imj.70253
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00